Smad6甲基化抑制NFκB活化与牙周炎症
本研究首次揭示TGFβ抑制TLR-NFκB信号依赖PRMT1诱导的Smad6甲基化,甲基化Smad6招募并促进MyD88降解,从而抑制NFκB活化。Smad6在牙龈上皮表达并甲基化,PRMT1-Smad6信号通过限制炎症促进组织稳态,干扰Smad6甲基化加重实验性牙周炎炎症与骨丧失。
要点
- TGFβ经PRMT1诱导Smad6甲基化,招募MyD88并促其降解,抑制NFκB活化。
- Smad6在牙龈上皮表达并甲基化,PRMT1-Smad6信号限制炎症、维持稳态。
- 干扰Smad6甲基化加重实验性牙周炎炎症与骨丧失。
核心结论
- TGFβ抑制TLR-NFκB信号由PRMT1诱导的Smad6甲基化介导,该机制在牙周组织中限制炎症并维持稳态。
研究设计与样本
- 基础实验研究,采用实验性牙周炎模型,具体样本量与设计细节原文未报告。
主要发现
- TGFβ抑制TLR-NFκB信号的能力由PRMT1诱导的Smad6甲基化介导。
- 甲基化Smad6招募MyD88并促进MyD88降解,从而抑制NFκB活化。
- Smad6在牙龈上皮表达并甲基化,PRMT1-Smad6信号通过限制炎症促进组织稳态。
- 干扰Smad6甲基化加重实验性牙周炎炎症与骨丧失。
临床怎么用
- 调控PRMT1-Smad6信号可作为调节牙周炎宿主免疫反应的新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The balance between pro- and anti-inflammatory signals maintains tissue homeostasis and defines the outcome of chronic inflammatory diseases such as periodontitis, a condition that afflicts the tooth-supporting tissues and exerts an impact on systemic health. The induction of tissue inflammation relies heavily on Toll-like receptor (TLR) signaling, which drives a proinflammatory pathway through recruiting myeloid differentiation primary response gene 88 (MyD88) and activating nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB). TLR-induced production of proinflammatory cytokines and chemokines is reined in by anti-inflammatory cytokines, including the transforming growth factor β (TGFβ) family of cytokines. Although Smad6 is a key mediator of TGFβ-induced anti-inflammatory signaling, the exact mechanism by which TGFβ regulates TLR proinflammatory signaling in the periodontal tissue has not been addressed to date. In this study, we demonstrate for the first time that the ability of TGFβ to inhibit TLR-NFκB signaling is mediated by protein arginine methyltransferase 1 (PRMT1)-induced Smad6 methylation. Upon methylation, Smad6 recruited MyD88 and promoted MyD88 degradation, thereby inhibiting NFκB activation. Most important, Smad6 is expressed and methylated in the gingival epithelium, and PRMT1-Smad6 signaling promotes tissue homeostasis by limiting inflammation. Consistent with this, disturbance of Smad6 methylation exacerbates inflammation and bone loss in experimental periodontitis. The dissected mechanism is therapeutically important, as it highlights the manipulation of PRMT1-Smad6 signaling as a novel promising strategy to modulate the host immune response in periodontitis.
引用
- Zhang T, Wu J, Ungvijanpunya N, et al. Smad6 Methylation Represses NFκB Activation and Periodontal Inflammation. J Dent Res. 2018. PMID: 29420098. doi:10.1177/0022034518755688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。